The % T-Helper-17 (Th17) marker plays an important role in the evaluation of the immune system's state, particularly in the context of inflammation and autoimmunity. Th17 cells, a subset of T-helper cells, are primarily known for their involvement in inflammatory responses and their role in autoimmune diseases. They function by producing interleukin-17 (IL-17) and other pro-inflammatory cytokines, which are critical in the body's defense against certain pathogens, especially at mucosal barriers. However, dysregulation or overactivity of Th17 cells can contribute to the pathogenesis of various autoimmune and inflammatory conditions. Elevated levels of Th17 cells can indicate a predisposition towards certain autoimmune conditions, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, among others. Conversely, a reduction in Th17 levels might be indicative of compromised mucosal immunity.
The % T-Helper-2 Cell marker is a critical component in evaluating immune system functionality, particularly in the context of immune system balance and potential disorders. T-Helper-2 cells, often denoted as Th2 cells, are a subtype of T cells that play a significant role in the immune system's humoral immunity response. These cells are primarily involved in stimulating B cells to produce antibodies, especially in response to extracellular pathogens such as parasites and bacteria. The % T-Helper-2 Cell marker is used to assess the balance between Th1 and Th2 cells, which is essential for maintaining immune system homeostasis. A disproportionate increase in Th2 cells, often indicated by a higher percentage in the panel, is associated with certain immunological conditions. Specifically, Th2 dominance may result in heightened responses to allergens, contributing to allergic reactions, asthma, and other atopic disorders. It can also be implicated in certain autoimmune diseases where an overactive humoral response is observed. Furthermore, the Th1/Th2 balance is crucial in understanding the immune response to various pathogens and in autoimmune conditions. An imbalance, such as an elevated Th2, might suggest a shift away from cell-mediated immunity (Th1) and could provide insights into the patient's susceptibility to infections, their response to vaccines, or the progression of autoimmune diseases.
percentage of small, dense low-density lipoprotein cholesterol
Dietary Peptide Related Markers
Dietary Peptide Related Markers
1-Methyl-Histidine is a compound found in urine that is measured as part of an Amino Acid Profile, Quantitative (Qn) test. This marker is particularly important because it can provide valuable insights into muscle metabolism and dietary protein intake. 1-Methyl-Histidine is a breakdown product of an amino acid called histidine, which is found in significant amounts in muscle tissue and certain proteins, particularly those from animal sources like meat. When you consume these proteins, your body metabolizes them, and one of the by-products is 1-Methyl-Histidine, which is then excreted in the urine. Elevated levels of 1-Methyl-Histidine in urine can indicate increased muscle turnover or high dietary intake of meat, reflecting how much protein your body is processing and breaking down. This can be particularly useful in various clinical settings, such as monitoring protein metabolism in athletes, assessing nutritional status, and diagnosing or managing conditions that affect muscle health. Conversely, low levels might suggest inadequate protein intake or impaired muscle metabolism. Thus, measuring 1-Methyl-Histidine in urine helps clinicians understand more about a person's dietary habits, muscle health, and overall metabolic state, making it a valuable tool in nutritional and medical assessments.
A component of the dietary peptide anserine.
A component of the dietary peptide anserine.
derived from the dipeptide anserine
Dietary Peptide Related Markers
Dietary Peptide Related Markers
Dietary Peptide Related Markers
Dietary Peptide Related Markers
A component of the dietary peptide anserine.
Dietary Peptide Related Markers
A component of the dietary peptide anserine.
1,5-Anhydroglucitol (1,5-AG) is a monosaccharide that plays a critical role as a biomarker in the assessment of intermediate glycemic control in individuals, particularly those with diabetes. Unlike conventional markers such as glycated hemoglobin (HbA1c), which reflects average blood glucose levels over a period of approximately two to three months, 1,5-AG offers a more immediate view of glycemic control, usually reflecting fluctuations in blood glucose levels over a shorter period of one to two weeks. This distinct temporal sensitivity arises from its unique physiological mechanism: 1,5-AG is typically maintained at a constant level in the bloodstream, but when blood glucose levels rise above the renal threshold (approximately 180 mg/dL), glucose competes with 1,5-AG for reabsorption in the kidneys. As a result, elevated blood glucose levels lead to an increased excretion of 1,5-AG in urine, thereby reducing its serum concentration. This biomarker's sensitivity to short-term glycemic excursions makes it particularly useful in detecting and monitoring postprandial hyperglycemia and glycemic variability, both of which are significant factors in the pathogenesis of diabetic complications and may not be adequately captured by HbA1c alone. Consequently, 1,5-AG serves as a valuable adjunct to HbA1c in providing a comprehensive picture of glycemic control. It is particularly beneficial in situations where HbA1c readings may be misleading, such as in cases of hemoglobinopathies, recent changes in diabetes therapy, or pregnancy. Moreover, the assessment of 1,5-AG levels can be instrumental in guiding therapeutic adjustments in diabetes management, aiming for a holistic approach to the control of both fasting and postprandial blood glucose levels. However, it's important to note that the interpretation of 1,5-AG levels must be done cautiously, considering factors like renal function, as renal impairment can affect its accuracy as a glycemic marker. Reference Range(s): Age Male (mcg/mL) Female (mcg/mL) ≤1 year Not established Not established 2-17 years 15.0-38.0 11.2-35.7 ≥18 years 7.3-36.6 7.5-28.4